Niowave, Inc.

Lansing, MI

UEI
WJLJSN2AT8P1
CAGE
4FV39
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1012 N Walnut St, Lansing, MI 48906, USA
Website
niowaveinc.com
Founded
2005
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Niowave, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Niowave is currently in phase 2 of a three-phase program supported by the nnsa MO-99 CA to produce 10 KCI/week (1,550… Grant · DENA0004012 National Nuclear Security Administration $17,194,899
Fabrication and testing of advanced fuels for lead and sodium cooled fast reactors Grant · DESC0020857 Office of Science $179,835
Niowave INC. The base MOD provides $5M, which fully funds this 3-year award. Grant · DENA0003925 National Nuclear Security Administration $30,000,000
Sbir phase i Contract · N6833519C0390 Naval Air Warfare Center $139,992
A corrosion test station for improved characterization and examination capabilities of advanced nuclear reactor fuels… Grant · DESC0018691 Office of Science $866,148

About Niowave, Inc.

Niowave, Inc. is a domestic supplier of medical and industrial radioisotopes from uranium and radium. Through federal contracts, Niowave, Inc. has provided research and development services related to advanced fuels for lead and sodium cooled fast reactors. Through federal grants, Niowave, Inc. has received funding to produce molybdenum-99, a medical radioisotope, as well as to conduct research on fabrication and testing of advanced nuclear fuels.

Specifically, Niowave, Inc. was awarded a $239,983 SBIR Phase I federal contract by the Department of the Navy Secretary of the Navy Office of Naval Research to conduct research and development related to advanced fuels. This was a small business set aside contract.

Niowave, Inc. has also received over $34 million in federal grants from the Department of Energy's National Nuclear Security Administration and Office of Science. A $30 million cooperative agreement from the NNSA provides funding to expedite commercial-scale production and distribution of molybdenum-99 medical radioisotopes. Additionally, a $179,835 project grant from the Office of Science supports research on fabrication and testing of advanced fuels for fast reactors.

Quick answers

What is Niowave, Inc.'s UEI?

Niowave, Inc.'s Unique Entity ID (UEI) in SAM.gov is WJLJSN2AT8P1.

What is Niowave, Inc.'s CAGE code?

Niowave, Inc.'s CAGE code is 4FV39.

What is Niowave, Inc.'s primary NAICS code?

Niowave, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Niowave, Inc. located?

Niowave, Inc.'s physical address in SAM.gov is 1012 N Walnut St, Lansing, MI 48906, USA.

Is Niowave, Inc. registered in SAM.gov?

Yes. Niowave, Inc.'s SAM.gov registration is active through October 23, 2026.

What is Niowave, Inc.'s most recent federal award?

Niowave, Inc.'s most recent federal grant award is Niowave is currently in phase 2 of a three-phase program supported by the nnsa MO-99 CA to produce 10 KCI/week (1,550… (DENA0004012), from National Nuclear Security Administration, on December 3, 2021.

On GovTribe

See Niowave, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors